EVICR.net is a platform for multinational clinical research in Ophthalmology in Europe and a structure to support multinational Investigator-Initiated Research (IIR). IIR are studies instigated by academic researchers.
If you are an Investigator and you have an idea for a multinational clinical study, EVICR.net helps you to develop your idea in a clinical research study in ophthalmology.
Consult the EVICR.net Investigator Initiated Research (IIR) leaflet for further information.
Ongoing Investigator Initiated Research
1. ClinicalTrials.gov nº NCT04281186
RECOGNISED –Retinal and Cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia
Coordinating Investigator: R. Simó, Barcelona, Spain (CS74)
Participating Centres (10): Denmark, Italy, Netherlands, Portugal, Spain and UK
Sponsor: Fundació Hospital Universitari Vall D’Hebron, VHIR, represented by Prof. Rafael Simó.
Financial Support: Horizon 2020 – Project nº 847749
2. IRD Survey
EVICR.net is conducting an International Survey entitled “Current management of Inherited Retinal Diseases (IRD) subjects in Europe”.
Financial Support: Novartis
3. ClinicalTrials.gov nº NCT02495181
EudraCT nº 2015-001368-20
ATLANTIC – A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept with Adjunctive Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy
Coordinating Investigator: Rufino Silva, Coimbra, Portugal (CS82)
Participating Centres (18): Albacete, Barcelona (4), Braga, Coimbra (2), Las Palmas, Leiria, Lisbon (4), Oviedo, Porto (2), Vila Franca de Xira
IIR Grant: Bayer
4. ClinicalTrials.gov nº NCT03235856
REDCAKE – Retrospective Digital Computer Analysis of Keratoconus Evolution
Coordinating Investigator: Jos Rozema, Antwerp, Belgium (CS12)
Participating Centres (13): Belgium, Germany, Italy, Spain, Switzerland, Netherlands, Portugal
Sponsor: Antwerp University Hospital
IIR Grant: Flemish Fund for Research
5. ClinicalTrials.gov nº NCT03349801
MACUSTAR – Intermediate AMD: Development of novel clinical endpoints for clinical trials in patients with a regulatory and patient access intention
Coordinating Investigator: Frank Holz, Bonn, Germany (CS15)
Participating Centres (20): Denmark, France, Germany, Italy, Netherlands, Portugal, United Kingdom
Sponsor: University Hospital Bonn
Financial Support: IMI2 and EFPIA – Project nº 116076
Other ongoing Investigator Initiated Research
1. ClinicalTrials.gov nº NCT03297515
MADEOS – Prospective, randomised, double-blind study to assess the Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease (Macular Degeneration Omega-3 Study)
Participating Centres (5): France (1), Germany (1), Italy (3)
Sponsor: Ophthalmos Research and Educational Institute